PRIMARY CARDIAC LYMPHOMA

PRIMARY CARDIAC LYMPHOMA was reported 16 times

PRIMARY CARDIAC LYMPHOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific CD20-directed CD3 T Cell Engager [EPC] 2 0.0005
1 Topoisomerase Inhibitor [EPC] 6 0.0001
2 Microtubule Inhibitor [EPC] 8 0.0000
3 Alkylating Drug [EPC] 11 0.0000
4 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
5 Corticosteroid [EPC] 7 0.0000
6 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
7 Thalidomide Analog [EPC] 2 0.0000
8 CD20-directed Cytolytic Antibody [EPC] 1 0.0000